These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25838394)

  • 1. Intratumoral Heterogeneity: From Diversity Comes Resistance.
    Pribluda A; de la Cruz CC; Jackson EL
    Clin Cancer Res; 2015 Jul; 21(13):2916-23. PubMed ID: 25838394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells: an approach to identify newer therapeutic targets.
    Srivastava S; Krishna S
    J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
    Easwaran H; Tsai HC; Baylin SB
    Mol Cell; 2014 Jun; 54(5):716-27. PubMed ID: 24905005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral functional heterogeneity and chemotherapy.
    Sipos F; Constantinovits M; Műzes G
    World J Gastroenterol; 2014 Mar; 20(10):2429-32. PubMed ID: 24627580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells: implications for cancer therapy.
    Dawood S; Austin L; Cristofanilli M
    Oncology (Williston Park); 2014 Dec; 28(12):1101-7, 1110. PubMed ID: 25510809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of tumor-cell heterogeneity.
    Schnipper L
    N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
    [No Abstract]   [Full Text] [Related]  

  • 11. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
    Nijman SMB
    Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do epigenetic drug treatments hold the key to killing cancer progenitor cells?
    Byler S; Sarkar S
    Epigenomics; 2014 Apr; 6(2):161-5. PubMed ID: 24811783
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
    Kim JJ; Rai R
    Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells in the etiology and treatment of cancer.
    Zhang M; Rosen JM
    Curr Opin Genet Dev; 2006 Feb; 16(1):60-4. PubMed ID: 16377171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
    Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
    Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
    Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
    Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells to suppress acquired chemotherapy resistance.
    Vidal SJ; Rodriguez-Bravo V; Galsky M; Cordon-Cardo C; Domingo-Domenech J
    Oncogene; 2014 Sep; 33(36):4451-63. PubMed ID: 24096485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
    Skipper HE; Simpson-Herren L
    Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy in heterogeneous cultures of cancer cells with interconversion.
    Dilão R
    Phys Biol; 2014 Nov; 12(1):016002. PubMed ID: 25429401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.